Intravenous challenge with heparins in patients with delayed-type skin reactions after subcutaneous administration of the drug.
Trautmann
A
A
Department of Dermatology, University of Würzburg, Germany.
Bröcker
E B
EB
Klein
C E
CE
D003872:Dermatitis / Q000209:etiology; D003875:Drug Eruptions / Q000209:etiology*; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000209:etiology*; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D012882:Skin Tests
D006493:Heparin